AP887A - Novel 5-0-deoaminyl 6-0-methyl erythronolide a derivatives method for preparing same application thereof for preparing biologically active products. - Google Patents

Novel 5-0-deoaminyl 6-0-methyl erythronolide a derivatives method for preparing same application thereof for preparing biologically active products. Download PDF

Info

Publication number
AP887A
AP887A APAP/P/1998/001210A AP9801210A AP887A AP 887 A AP887 A AP 887A AP 9801210 A AP9801210 A AP 9801210A AP 887 A AP887 A AP 887A
Authority
AP
ARIPO
Prior art keywords
formula
radical
compound
methyl
carbon atoms
Prior art date
Application number
APAP/P/1998/001210A
Other languages
English (en)
Other versions
AP9801210A0 (en
Inventor
Alain Bonnet
Michel Delthil
Alain Mazurie
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP887(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AP9801210A0 publication Critical patent/AP9801210A0/xx
Application granted granted Critical
Publication of AP887A publication Critical patent/AP887A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
APAP/P/1998/001210A 1995-09-11 1996-09-10 Novel 5-0-deoaminyl 6-0-methyl erythronolide a derivatives method for preparing same application thereof for preparing biologically active products. AP887A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9510601A FR2738571B1 (fr) 1995-09-11 1995-09-11 Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
PCT/FR1996/001384 WO1997010251A1 (fr) 1995-09-11 1996-09-10 Nouveaux derives de la 5-0-desosaminyl 6-0-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs

Publications (2)

Publication Number Publication Date
AP9801210A0 AP9801210A0 (en) 1998-03-31
AP887A true AP887A (en) 2000-11-10

Family

ID=9482423

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001210A AP887A (en) 1995-09-11 1996-09-10 Novel 5-0-deoaminyl 6-0-methyl erythronolide a derivatives method for preparing same application thereof for preparing biologically active products.

Country Status (34)

Country Link
US (1) US5969161A (fr)
EP (1) EP0854880B1 (fr)
JP (1) JP4332218B2 (fr)
KR (1) KR100457755B1 (fr)
CN (2) CN1237069C (fr)
AP (1) AP887A (fr)
AR (1) AR004195A1 (fr)
AT (1) ATE266035T1 (fr)
AU (1) AU708811B2 (fr)
BG (1) BG63822B1 (fr)
BR (1) BR9610503A (fr)
CA (1) CA2228670C (fr)
CZ (3) CZ294866B6 (fr)
DE (1) DE69632405T2 (fr)
DK (1) DK0854880T3 (fr)
EA (1) EA000575B1 (fr)
EE (1) EE03774B1 (fr)
ES (1) ES2219698T3 (fr)
FR (1) FR2738571B1 (fr)
GE (1) GEP20022838B (fr)
HK (2) HK1016187A1 (fr)
HU (1) HU227565B1 (fr)
IL (1) IL123550A (fr)
MX (1) MX9801859A (fr)
NO (2) NO312678B1 (fr)
PL (1) PL183652B1 (fr)
PT (1) PT854880E (fr)
RO (1) RO120137B1 (fr)
SI (1) SI0854880T1 (fr)
SK (3) SK285995B6 (fr)
TR (1) TR199800438T1 (fr)
UA (1) UA53628C2 (fr)
WO (1) WO1997010251A1 (fr)
ZA (1) ZA966837B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100441591C (zh) * 1996-09-04 2008-12-10 艾博特公司 酮基内酯类化合物，其用途和制备方法以及药用组合物
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
EP1483277A4 (fr) * 2002-02-15 2007-10-03 Merckle Gmbh Conjugues de composes biologiquement actifs, procedes de preparation et d'utilisation, et formulation et applications pharmaceutiques
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
JP2005536465A (ja) * 2002-05-13 2005-12-02 エナンタ ファーマシューティカルズ インコーポレイテッド ６，１１二環式エリスロマイシン誘導体
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
WO2005070918A1 (fr) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Procede de preparation de derives bicycliques 6-11 d'erythromycine
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (fr) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. Derives d'erythromycine 6-11 bicyclique
WO2005070113A2 (fr) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. Derives d'erythromycine bicycliques 9-n substitues en c6-c11
JP2008522978A (ja) 2004-12-07 2008-07-03 エナンタ ファーマシューティカルズ インコーポレイテッド ３，６−ビシクロライド
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
WO2006065721A2 (fr) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Bicyclolides de 11, 12-lactone
US7312201B2 (en) 2004-12-13 2007-12-25 Enanta Pharmaceuticals, Inc. Tetracyclic bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
EP1907392A1 (fr) * 2005-07-26 2008-04-09 Merckle Gmbh Conjugues macrolides de composes de pyrrolizine et d'indolizine comme inhibiteurs de la 5-lipooxygenase et de la cyclooxygenase
JP5642548B2 (ja) * 2007-09-17 2014-12-17 エナンタ ファーマシューティカルズ インコーポレイテッド ６，１１−架橋ビアリールマクロライド
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
CN103232501A (zh) * 2013-04-11 2013-08-07 宜昌东阳光药业股份有限公司 阿奇霉素或阿奇霉素的中间体脱去克拉定糖化合物的制备工艺

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272110A2 (fr) * 1986-12-17 1988-06-22 Taisho Pharmaceutical Co. Ltd Dérivés de l'érythromycine A et leur méthode de préparation
EP0619320A1 (fr) * 1991-12-27 1994-10-12 Taisho Pharmaceutical Co. Ltd Derive de 5-o-desosaminylerythronolide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272110A2 (fr) * 1986-12-17 1988-06-22 Taisho Pharmaceutical Co. Ltd Dérivés de l'érythromycine A et leur méthode de préparation
EP0619320A1 (fr) * 1991-12-27 1994-10-12 Taisho Pharmaceutical Co. Ltd Derive de 5-o-desosaminylerythronolide
EP0619319A1 (fr) * 1991-12-27 1994-10-12 Taisho Pharmaceutical Co. Ltd Derive de 5-o-desosaminylerythronolide

Also Published As

Publication number Publication date
JP4332218B2 (ja) 2009-09-16
IL123550A0 (en) 1998-10-30
PT854880E (pt) 2004-09-30
ES2219698T3 (es) 2004-12-01
HUP9802930A3 (en) 1999-12-28
CA2228670A1 (fr) 1997-03-20
EP0854880A1 (fr) 1998-07-29
BG63822B1 (bg) 2003-02-28
SK283690B6 (sk) 2003-12-02
DE69632405T2 (de) 2005-05-19
CN1237069C (zh) 2006-01-18
AP9801210A0 (en) 1998-03-31
RO120137B1 (ro) 2005-09-30
UA53628C2 (uk) 2003-02-17
KR19990044543A (ko) 1999-06-25
CZ294865B6 (cs) 2005-04-13
NO981053D0 (no) 1998-03-10
CZ289945B6 (cs) 2002-04-17
WO1997010251A1 (fr) 1997-03-20
NO981053L (no) 1998-03-10
EP0854880B1 (fr) 2004-05-06
HUP9802930A1 (hu) 1999-04-28
US5969161A (en) 1999-10-19
GEP20022838B (en) 2002-11-25
EE9800065A (et) 1998-08-17
NO20021111D0 (no) 2002-03-06
SK29498A3 (en) 1998-12-02
NO20021111L (no) 1998-03-10
FR2738571A1 (fr) 1997-03-14
HK1016187A1 (en) 1999-10-29
ZA966837B (en) 1997-08-13
HU227565B1 (en) 2011-08-29
TR199800438T1 (xx) 1998-05-21
HK1041489B (zh) 2006-09-08
CZ294866B6 (cs) 2005-04-13
DK0854880T3 (da) 2004-08-16
NO315048B1 (no) 2003-06-30
BR9610503A (pt) 1999-07-06
CN1070498C (zh) 2001-09-05
DE69632405D1 (de) 2004-06-09
ATE266035T1 (de) 2004-05-15
AU708811B2 (en) 1999-08-12
CZ71798A3 (cs) 1998-07-15
NO312678B1 (no) 2002-06-17
MX9801859A (es) 1998-11-30
EE03774B1 (et) 2002-06-17
SK285853B6 (sk) 2007-09-06
EA199800288A1 (ru) 1998-08-27
PL326274A1 (en) 1998-08-31
SK285995B6 (sk) 2008-01-07
AR004195A1 (es) 1998-11-04
CA2228670C (fr) 2005-04-12
HK1041489A1 (en) 2002-07-12
FR2738571B1 (fr) 1997-10-17
EA000575B1 (ru) 1999-12-29
IL123550A (en) 2002-09-12
CN1201462A (zh) 1998-12-09
SI0854880T1 (en) 2004-12-31
KR100457755B1 (ko) 2005-02-28
CN1319602A (zh) 2001-10-31
PL183652B1 (pl) 2002-06-28
JPH11512416A (ja) 1999-10-26
AU6991096A (en) 1997-04-01
BG102312A (en) 1998-09-30

Similar Documents

Publication Publication Date Title
AP887A (en) Novel 5-0-deoaminyl 6-0-methyl erythronolide a derivatives method for preparing same application thereof for preparing biologically active products.
Baker et al. Modification of macrolide antibiotics. Synthesis of 11-deoxy-11-(carboxyamino)-6-O-methylerythromycin A 11, 12-(cyclic esters) via an intramolecular Michael reaction of O-carbamates with an. alpha.,. beta.-unsaturated ketone
RU2230748C2 (ru) Способ получения кларитромицина в виде кристаллов формы ii
EP0109253A2 (fr) Dérivé épimère de l'azahomoérythromycine A et intermédiaires
EP0226202A2 (fr) Synthèse de composés du type podophylotoxine
EP0496160B1 (fr) Conversion synthétique de bryostatin 2 en bryostatin 1
HU193157B (en) Process for preparing 4"-epi-erythromycin a and derivatives thereof
EP0201166B1 (fr) Dérivés d'érythromycine
EP0245013A1 (fr) Dérivés de l'érythromycine
EP0097925B1 (fr) Dérivés de la tylosine, leur méthode de préparation et les compositions pharmaceutiques les contenant
EP0202111B1 (fr) Dérivés de la mycaminosyl tylonolide à activité antibactérienne et leur fabrication
EP1117671A2 (fr) Technique de synthese aux fins de la preparation d'etoposide, un agent antineoplasique
JP2004536075A (ja) Ｏ−アリルエリスロマイシン誘導体を機能化するためのアリール化方法
EP0259496A1 (fr) Derives d'antibiotiques de cervinomycine et procede de preparation
EP0087915B1 (fr) Oléandomycines et erythromycines semi-synthétiques
El Khadem et al. Synthesis of 3-amino-2, 3, 6-trideoxy-d-ribo-and-l-lyxo-hexofuranoses suitable for nucleoside synthesis
US20050159371A1 (en) Process for producing erythromycin a derivative
AU2002357482B2 (en) Method for the production of desclarithromycin, and intermediate products
SE445556B (sv) Nya 3"-acylerade makrolidantibiotika
CA1128506A (fr) Derives de 4"-erythromycine a semi-synthetiques
WO2005021567A1 (fr) Derives o-alkyle de macrolides et d'azalides et processus d'obtention stereoselectif
JPH11116592A (ja) ４”−置換エリスロマイシンａ誘導体
JPS6360030B2 (fr)
HU211493A9 (en) Derivatives 10, 11, 12, 13-tetrahydrodesmycosin, processes for preparation and use thereof in pharmaceuticals
KR20010100197A (ko) 에리스로마이신 에이 9-오-트로필옥심 유도체를 이용한클라리스로마이신의 제조방법